Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

196
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

04/26/2012 | 05:46am US/Eastern

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
05:01p GLAXOSMITHKLINE : The Law Office of Melinda J. Helbock, A.P.C. Announces That It..
08:37a GLAXOSMITHKLINE : GSK receives approval for Encruse Ellipta in Japan for the tre..
03:16a GLAXOSMITHKLINE : The Law Office of Melinda J. Helbock, A.P.C. Announces That It..
03/26 AstraZeneca, Glaxo Sign Up For 100,000 Genomes Project Consortium
03/26 NOVARTIS : BUSINESS INSIDE CHRONICLE BATH Family's greatest hope yet in the figh..
03/26 GLAXOSMITHKLINE : Glaxo Gets Approval For Encruse Ellipta, Two Other Products In..
03/26 GLAXOSMITHKLINE : GSK receives approval for Encruse® Ellipta® in Japan for the t..
03/25 GLAXOSMITHKLINE : GSK and Theravance announce outcome of US FDA Advisory Committ..
03/25 GLAXOSMITHKLINE : UK Department of Health Updates on 2 Proposed Ebola Vaccines
03/24 GLAXOSMITHKLINE : GSK’s 2015 Discovery Fast Track Challenge seeks early dr..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF